Market Overview

Teva Announces Signing of New $3B Syndicated Revolving Credit Line

Related TEVA
Benzinga's M&A Chatter for Monday April 27, 2015
Benzinga's M&A Chatter for Wednesday April 22, 2015
Taro's Stock Has An Upside Potential (Seeking Alpha)

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

Posted-In: News Financing


Related Articles (TEVA)

Around the Web, We're Loving...